Try our Advanced Search for more refined results
Life Sciences - November, 2022
283 articles
- CDC Broke Gilead HIV Research Deal, Claims Court Rules
- Riding Circuit: December's Notable Appellate Arguments
- Immig. Board Told To Consider Mom's Missed Hearing Excuse
- Femtech Cos. Should Prioritize Pursuing IP, Attys Say
- 7th Circ. OKs Indiana Fetal Remains Requirement
- J&J Says Amgen Biosimilar Infringes Patents For $9B Product
- Medical Pot User Claims Labcorp Wrongly Denied Him A Job
- FTC Told DOD Designation Helps Illumina-Grail Deal Appeal
- Roche Escapes Ex-Service Member's Anti-Malarial Drug Suit
- Gov't Contracts Of The Month: Blue Origin, SpaceX, Internet
- HHS Plans ADR Overhaul For Drug Discount Rows
- The Fed. Circ. In November: The Presumption Of TM Validity
- Corteva Buys Latham-Guided Plant Science Co. In $1.2B Deal
- NJ Judge Sends 33 J&J Implant Suits Back To State Court
- NY Nursing Home's Neglect Tied To Patient Deaths, State Says
- Biopharm Co. Stockholders Challenge Director Pay In Del. Suit
- Abbott Sued Over Formula Linked To Premature Baby Death
- Johns Hopkins Breached Keytruda Deal, Merck Sharp Says
- Drugmaker Astellas Has Claims For DOJ Settlement Coverage
- Roundup Buyers Seek OK Of $45M False Ad Settlement
- Time For USPTO To End Marijuana Company TM Disclaimers
- EU Reaches €157M Settlement Over Chemical Cartel
- Gordon & Rees Hires Faegre Drinker Product Liability Duo
- Shire Wants 11th Circ. To Review Kidney Failure Lawsuit
- Honeywell Hit With $10M Suit Over 'Deformed' N95 Masks
- Boston Scientific Acquires Medical Tech Co. In $615M Deal
- Tribal Corp, Stanford Sort Out Contract Fight Over Drug IP
- Juno Urges Justices To Hold Patent Case Until Amgen Ruling
- Lack Of Facts Dooms Class Cert Over Takeda Gout Drug
- Monster Leads Push For Litigation Committee In Vital's Ch. 11
- N95 Seller's Attys Sanctioned Over Missed 3M Deadlines
- Procter & Gamble Throat Drops Have No Lemon, Suit Says
- Fed. Circ. Urged To Revive Lymphoma Drug Patent Case
- 3M On Hook For One Deductible For Warming Device Defense
- Catching Up With Delaware's Chancery Court
- Coppertone Parent Hit With Fraud Suit Over Sunscreen Labels
- BigLaw Firms Help Create Term Sheet Template For Startups
- Law Schools Are Right To Steer Clear Of US News Rankings
- How Firms Are Getting The Most Out Of Their Pro Bono Work
- The 2022 Law360 Pulse Social Impact Leaders
- Feds Seek Prison For Exec's FDA Fraud After 1st Circ. Flip
- UK Litigation Roundup: Here's What You Missed In London
- FDA Asks Companies For Cigarette Packaging Plans
- 5 Years In, Opioid Attys Talk Historic Saga's Progress & Future
- Ex-Indivior Exec Says 5-Year Federal Program Ban Isn't Fair
- Holmes Should Serve 11-Year Sentence In Texas, Judge Says
- High Court Told Plenty Of Circuit Judges Disagree On FCA
- NC Sues 3M, DuPont Over 'Forever Chemical' Contamination
- DEA Legalizes Cocaine Derivative, Rejects Pot Comparisons
- Del. Jury Says AngioDynamics Infringes CR Bard Patents
- Pharma Co. Asks For Stay To Appeal 'Orange Book' Delisting
- Why BIPA Litigation Could Be A Death Knell To Cannabis Cos.
- Honigman Announces Corporate Partner In Chicago
- Litigation Funders Seek Transparency In Disclosure Debate
- 7 Key Takeaways For Litigating Willful Patent Infringement
- 4 Firms, 2 Years, 1 Suit And, Finally, A Done UnitedHealth Deal
- Ga. Supreme Court Revives 6-Week Abortion Ban
- J&J Unit Invalidates Spinal Implant Patent On Eve Of Trial
- Court Told Gov't Admitted To License Agreement In Nixed Suit
- Claims Court Finds CDC Broke Gilead Deal Over HIV Research
- Tribes Urge Judge To Find Ore. Irrigation Plan Violated ESA
- Bayer Alka-Seltzer Falsely Hypes Honey And Lemon, Suit Says
- Meridian Bioscience's $1.53B Sale Clears Antitrust Hurdles
- Abbott Tries Again To Sink HIV Test Patent
- FDA Targets 5 CBD Cos. Hawking Food And Beverages
- Cos. Should Start Thinking About IP Protection For Quantum
- PREP Immunity Applies To Swab Patent Suit, Fed. Circ. Told
- Anticipating The New Congress' Private Sector Investigations
- Ex-Rutgers Prof Accused Of Defamation Over Job Reference
- 5 Principles For Better Professional Development Programs
- Teva, Allergan Finalize Multibillion-Dollar Global Opioid Deals
- PTAB Told Chemical Co.'s Tech Has 'Full Promise' Of CRISPR
- Holmes Faces Uphill Battle Fighting 11-Year Prison Term
- Univar Slapped With ERISA Suit Over Unpaid Contributions
- UnitedHealth Closes Merger But DOJ Keeps Fighting
- WIPO Says China Is Filing The Most Patent, TM Applications
- My Favorite Law Prof: How I Learned To Practice With Passion
- Ga. Court Is Asked To Enforce Abortion Law During Appeal
- Merck To Buy Bone Marrow Cancer Firm In $1.35B Deal
- Attys Secure $91.7M In Monsanto PCB Suit
- Catching Up With Delaware's Chancery Court
- Clinical Trial Co. CEO Can't Avoid Fraud Charges Over Delay
- Hyman Phelps Brings On DOJ Consumer Protection Vet In DC
- DOJ Will Ask DC Circ. To Block UnitedHealth-Change Deal
- Del. Court Says Pharma Co. Must Delist 'Orange Book' Patent
- Biden Expected To Sign Pot Research Bill Into Law
- Sterigenics Prevails In Second Ethylene Oxide Trial
- Last Call For 2022 As IPO Prospects Line Up To Go Public
- FDA Faces Texas Suit Over Approval Of Abortion Drugs
- 1st Circ. Tosses Aegerion Rep's Drug Fraud Convictions
- Congress Should Pass Tillis-Coons Patent Eligibility Bill
- FTX Chaos, Texas Utility Reorg OK'd, Student Debt Relieved
- Fla. Commissioner Appeals Ruling Denying Pot Patients Guns
- Elizabeth Holmes Gets Over 11 Years For Theranos Fraud
- Exculpation Clause Ruling May Dissuade Some Ch. 11 Filings
- Sen. Lee Floats Bill To Drop Biosimilar Hurdle
- State AG Consumer Protection Shift Isn't An Election Fad
- All-Women White Collar Boutique Adds Ex-Boston Prosecutor
- Baxter Agrees To Drop Fraud, Patent Case Against B. Braun
- UK Litigation Roundup: Here's What You Missed In London
- Woman Hasn't Linked Emissions To Cancer, Sterigenics Says
- Holmes Likely To Get Prison With Pause For Appeal, Attys Say
- IP Forecast: Winery, Its Former Lawyer To Face Off In TM Row
- Akin Gump Gets Green Light To Represent Endo Claimants
- Allergan Drops Part Of IBS Drug Patent Suit Against MSN
- New Orleans Litigation Outfit Adds New Name Partner
- Sens. Pitch Bill To Streamline Research Into Schedule I Drugs
- Ill. City Says Express Scripts Spoiled Docs In Acthar Case
- NJ Pharma CEO Indicted In $4M Embezzlement Scheme
- Moderna Ruling Misses On 'Products Sold To US Government'
- Whistleblower Tells Justices FCA Dismissal Authority Limited
- Indivior Spars With States, Suboxone Buyers Over Trial Date
- Deals Rumor Mill: Binance, SBF, Forbes Media
- Bipartisan Marijuana Research Bill Headed To Biden's Desk
- J&J Tells Justices $302M Mesh Fine Part Of 'Dangerous' Trend
- Patient Wants Special Master DQ'd In J&J Hip Implant MDL
- Masimo Prevails As Judge Rules Ex-Exec Took Trade Secrets
- 8th Circ. Backs CVS Win In TCPA Suit Over Fax
- Elizabeth Holmes Slams Feds' Bid For 15 Years Behind Bars
- FDA Cracks Down On Vapes That Look Like Toys, Food
- What New Data On FCA Enforcement Tells Us
- In Pfizer Win, PTAB Says Rival's Gene Therapy Wasn't New
- N95 Seller Must Give 3M Discovery Or Face Sanctions
- How Mayo V. Prometheus Strays From Patent Precedent
- NYC Pharmacy Owners Plead Guilty To COVID Medicare Fraud
- Ky. Gov.'s Executive Order Allows Out-of-State Medical Pot
- Questions To Ask Before Making A Lateral Move As Partner
- Lawmakers Urge House Committee To Act On Pot Reform
- Veterinarian, Horse Trainer Get Prison Time In Doping Case
- CVS Drug Buyers Face Skeptical 9th Circ. In $121M Retrial Bid
- Fed. Circ. Allows AbbVie, J&J To Fend Off Imbruvica Generic
- Seagen Looks To Nix Daiichi Win In Cancer Drug Dispute
- E-Cig Company's Appeal Premature, FDA Tells DC Circ.
- Ill. City Can't Escape Overflowing Sewage Suit, Judge Says
- Corps Must Protect Okefenokee From Mine, Green Groups Say
- FCA Takeaways From Courts' Recent Approach To Escobar
- Chamber Urges Full 11th Circ. Review Of Ga. Roundup Case
- White House Wants $48B More For COVID, Ukraine Battles
- Natera Says Fed. Circ. Panel Rightly Axed DNA Test Patents
- McCarter & English Must Produce Docs In Biotech's Suit
- HHS, Drug Cos. Spar Over Pharmacy Limits In Discount Law
- Cooley-Led Oncology Firm Prices $94M IPO Below Range
- Ga.'s 6-Week Abortion Law Is Unconstitutional, Judge Rules
- 11th Circ. Doubts Link Of Deposition Texting To Arbitral Award
- Why PTAB 'Step 2B' Reversal Rates Are Falling
- Takeda To Pay $22M To End Challenge To 401(k) Lineup
- Walmart Confirms $3B Deal Over Pharmacies' Opioid Sales
- Drug Lobby Touts Pfizer's Kickback Challenge At High Court
- 6th Circ. Allows Opioid Judge's 'Unusual' Bellwether Approach
- Allergan, Merz's $54.4M Nameda Pay-For-Delay Deal Wins OK
- FTC Says "Orange Book" Abuse Blocks Drug Competition
- Sun Can't Say Allergan Used Secret Info To Grow Patent Suit
- Colorado Ballot Measure Decriminalizing Psychedelics Passes
- Catching Up With Delaware's Chancery Court
- NJ Man Cops To Insider Trading In Atty Info-Poaching Case
- My Favorite Law Prof: How I Learned To Argue Open-Mindedly
- Pot Researcher's Suit Over DEA Delays Gets Tossed
- Covington-Led Indivior To Buy US Drug Co. Opiant For $145M
- Holmes Seeks Home Confinement As Feds Urge 15 Yrs. Prison
- UK Litigation Roundup: Here's What You Missed In London
- 6th Circ. Won't Uproot Seed Biz's $7M Trade Secret Win
- Justices Seem Less Receptive To SG's Take On IP Cases
- Illumina Defends Grail Deal To FTC Commissioners After Win
- McKinsey Wants NY Opioid Suits Moved To Bankruptcy Court
- Feds Charge Ex-Mylan CIO With Insider Trading Scheme
- HHS Office To Avoid Anti-Abortion States For Pregnant Minors
- Medical Device Co. D R Burton Cleared In NC Patent Trial
- Viatris Sways Judge To Ax AstraZeneca Inhaler Patent
- Health Hires: Epstein Becker, Cassava Sciences
- Former Exec, Partners Of Vape Co. Drop Wrongful Firing Suit
- Pot Pill Co. Ordered To Pay $5M In SEC Fraud Suit
- ABA's No-Contact Rule Advice Raises Questions For Lawyers
- Big Pharma Opens New Front In War On Kickback Restrictions
- Amyris Investors Reach $13.5M Deal In Inflated Royalties Suit
- Flint Residents Shouldn't Depose Former EPA Head, DOJ Says
- Natural History Museum Fights To Pause COVID Coverage Suit
- FTC Mulls Proper Standard On Staffers' Juul-Altria Appeal
- Walgreens Faces $10B Opioid Trial Threat Despite $5B Deal
- Drug Atty Ads Risk 'Serious Harm,' W.Va. AG Tells High Court
- Teva Wins $176M From Eli Lilly In Migraine Drug Patent Trial
- Drug Buyers, States Want To Depose Indicted Ex-Taro Exec
- SoClean Wins TM Preliminary Injunction Fight At Fed. Circ.
- Firm Touts Diversity In Bid To Lead COVID Drug Claims Suit
- 4 Key Skills For An Effective Attorney Coaching Conversation
- Ga. City Worker Claims Race Bias During Pandemic
- Veteran Pharma Atty Joins Xenon As Chief Legal Officer
- NM Cannabis Co. Wants Insurance Suit Back In State Court
- Maryland And Missouri Legalize Pot, 3 Others Just Say No
- Control Of Congress Too Close To Call
- California, Vermont, Michigan Voters Back Abortion Rights
- Arkansas Voters Say No To Cannabis Legalization, Taxation
- 'Busy' Abbott Exec Has Time To Get Deposed, Judge Says
- Biopharma Co. Hit With Investor Action Over COVID Treatment
- 6th Circ. Says Depos Don't Force Trial Testimony In Flint Case
- Fox Rothschild Hires Loeb & Loeb IP Partner For NY Office
- Apotex Dodges Horizon Patent Suit Over Generic Pennsaid
- FCA Whistleblower Trying To 'Gin Up A Split,' High Court Told
- Ex-Theranos CEO Elizabeth Holmes Loses Bids For New Trial
- How Civilian Attorneys Can Help Veterans
- Attys Seek $1.65M Award For Altor-NantCell Deal In Del.
- From Courts To Polls: BigLaw Turns Out To Protect The Vote
- NY Judge Signs Off On J&J Counterfeit Meds Injunction
- Eli Lilly Flips Teva 'Free Ride' Claim As Migraine Trial Wraps
- Canadian Cancer Co. Accused Of Failing To Pay NC Exec
- Musk's $56B Tesla Pay Trial May Spur More Exec Comp Fights
- FDA Warns Court Not To Side With Sandoz In Drug Challenge
- 11th Circ. Backs Dismissal Of Zantac MDL 'Shotgun Pleadings'
- Cravath-Led Viatris Unveils Ophthalmology Buys Worth $750M
- W.Va. Urges 4th Circ. To Reverse Trans Medicaid Bias Ruling
- Walmart Rips 'Monday-Morning Quarterbacking' In Opioid Suit
- Delaware Gets $2.7M Atty Fee Request OK'd In Opioid Deal
- DuPont Spinoffs Must Face PFAS Claims, NC Justices Say
- Sterilization Plant Opposes New Suit For Workers
- Jury Clears Scrubs Startup Figs In Rival's False Ad Suit
- 11th Circ. Revives PGA Coach's Kidney Disease Suit
- Monsanto Asks Full 11th Circ. To Review Roundup Ruling
- Biogen Agrees To 12,000-Person Class In 401(k) Suit
- Catching Up With Delaware's Chancery Court
- Ex-Theranos Exec Balwani's Sentencing Delayed To December
- My Favorite Law Prof: How I Learned That Culture Shapes Law
- UT Austin Restaurant Loses COVID-19 Coverage Suit
- Alcon Gets PTAB Win In Eye Surgery IP Fight With J&J Unit
- 5 States Vote On Legalizing Pot, And 1 Votes On Psychedelics
- Justices Reject Case Over Patent 'Possession' Requirement
- HIV Drug Buyers Win Cert. In Gilead, Janssen Antitrust Suit
- SF-Walgreens Opioid Trial Called Off Amid Settlement Talks
- Opana Buyers' $145M Deal With $50M In Atty Fees Gets Final OK
- Feds Escape Suit Over Delayed Narcolepsy Drug
- FOIA Suit Over DNA Testing At Border Largely Resolved
- FDA, USPTO Set January Date For Public Input On Competition
- Key Bankruptcy Reforms In Reach, Whoever Wins Congress
- Settlement Comes Mid-Trial In Ga. Health FCA Case
- Pharma Cos. Keep Win In Off-Label Heart Drug Suits
- Texas Court Again Revives Suit Over Stryker Rep Assault
- McKesson OKs $141M Investor Deal Over Generic Price-Fixing
- Full 9th Circ. Passes On Atty's FCA Loss Against Allergan
- Fed. Circ. Doubts Vaccine Delivery IP Wrongly Axed By PTAB
- CBD Co. Says Judge's Memorandum On Counterclaims Wrong
- 5 Firms Lead Giant Biogene's Downsized $70M HK IPO
- Endo Claimants' Request To Hire Akin Gump Draws Objection
- FDA And FTC Warn CBD Shop Not To Sell False COVID Cures
- McCarter & English Aims To Shield Docs In Malpractice Suit
- What To Expect From The Post-Midterms Lame-Duck Session
- UK Litigation Roundup: Here's What You Missed In London
- Supreme Court Will Tackle Patent Enablement In Amgen Case
- CBD Co., Founder Ordered To Arbitrate Over $5M Tax Bill
- Walgreens Lied About Medicaid Compliance, 4th Circ. Told
- 5 Times That Stood Out In NY's Roller Coaster Opioid Case
- IP Forecast: VLSI Patent Battle Against Intel Goes For Round 4
- Calif. Court Delays SmileDirect's Competition Case
- 9 Legal Ethics Considerations In Natural Disaster Preparation
- 3rd Circ. Preview: Nov. Sees Uber Arbitration, Drug Discounts
- PTC Therapeutics Shareholder Sues In Del. Over Director Pay
- Study Claims Diagnostics Innovation Isn't Tied To Investments
- A Divided Congress May Increase Companies' Political Risks
- State Farm Tells 5th Circ. No Virus Coverage For Orthopedists
- NY Reaches $523M Opioid Deal With Teva
- After Pharmacy Deals, New Opioid Sellers In Legal 'Bull's-Eye'
- Moderna Loses Bid To Punt COVID Vax Patent Suit To Gov't
- Cherokee Nation Settles Ex-Bellwether Opioid Suit Vs. CVS
- 9th Circ.'s Weariness Of TCPA Award May Quell Big Paydays
- Union Says Long Island Hospital Owes Benefits Funds $1.7M
- Gov't Lodges Rival Early Win Bid In Gilead HIV Patent Row
- Calif. County Can Sue State Prison System Over Pollution
- 'Brilliant' GW Law Patent Scholar Dmitry Karshtedt Dies At 45
- Pollution Exclusion Frees Insurer From $175M Suit
- Sotera Health Hires Longtime GE Attorney As General Counsel
- Rwanda Alleges $40M Cancer Drug Investment Fraud
- PTAB Upholds IP Involved In $272M Genetic Testing Verdict
- Gilbert LLP Aims To Ensure It Gets Paid For Del. Opioid Work
- Rogers Explores Alternatives After DuPont Terminates Merger
- USPTO Administrative Patent Judge Joins Oblon McClelland
- CVS, Walgreens Offer $10B To End Nationwide Opioid Suits
- A Circuit-By-Circuit Guide To FCA Suits After High Court Snub
- 'Most Dangerous' Roundup Made Landscaper Sick, Jury Hears
- Feds Want Whistleblower's $1.4B Tamiflu FCA Suit Tossed
- Tribe Sues Golf Cart Co. Over Pandemic Malfunction Losses
- Fed. Circ. Iffy On Alvogen's Bid To Unblock Generic Opioid
- ITC Judge Clears COVID Swab Makers Of Infringing Patents
- Baker Botts Snags New M&A Co-Lead From Holland & Knight
- Cannabis Cos. Must Brace For Emerging Product Risks
- Ethicon, J&J Beat Back Attempt At New Pelvic Mesh Trial
- Cravath, Sullivan & Cromwell Drive J&J's $16.6B Abiomed Buy